EpiCARE designation of affiliated partners
EpiCARE -- a European Reference Network for Rare and Complex Epilepsies -- connects 28 expert centres in 13 Eruopean countries with the aim of aiding the diagnosis and treatment of rare epilepsy patients by using e-tools and cross-country e-consultance. EU member states without EpiCARE centres can nominate affiliated partners to join the network: EpiCARE Designation of affiliated partners
Award Winners Announced
ILAE-Europe is pleased to announce the recipients of the European Awards 2018. The awards were presented during the Welcome Ceremony of the 13th ECE on Sunday 26th August.
European Young Investigator Award - Birgit Frauscher (Austria/Canada)
2020 Course Applications
European Chapter Executives are invited to submit applications for funding of courses/symposia sponsored by ILAE-Europe during 2020.
Association of Levels of Specialized Care With Risk of Premature Mortality in Patients With Epilepsy
Exposure to specialist care is associated with incremental reductions in the hazard of premature mortality. Those referred to a comprehensive epilepsy program received the greatest benefit.
6 August, 2019
The subicular pyramidal neurons may be a key “switch” control of drug resistant epilepsy and represent a new potential target for precise treatments.
5 August, 2019
We are deeply saddened to announce that Jerzy Majkowski Emeritus Professor of Neurology and father of the Polish League Against Epilepsy, passed away on July 18 2019 in Warsaw at age 91. He contributed much in area of neurophysiology and epileptology. He trained and inspired a large number of…
31 July, 2019
In this Review, we focus on our understanding of the IL-1 receptor–Toll-like receptor 4 axis, the arachidonic acid–prostaglandin cascade, oxidative stress and transforming growth factor-β signalling associated with blood–brain barrier dysfunction, all of which are pathways that are activated in pharmacoresistant epilepsy in humans and that can be modulated in animal models to produce therapeutic effects on seizures, neuronal cell loss and neurological comorbidities.
30 July, 2019
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
Our study, the largest epilepsy WES study to date, confirms a convergence in the genetics of severe and less-severe epilepsies associated with ultra-rare coding variation, and it highlights a ubiquitous role for GABAergic inhibition in epilepsy etiology.
30 July, 2019
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community